The Democratic Socialists of America is a membership-based socialist organization with more than 90,000 dues-paying members. Anyone can join the DSA – there’s no admissions process, and you don’t even ...
The New York City chapter of the Democratic Socialists of America (DSA) has endorsed Assembly Member Claire Valdez’s campaign to succeed U.S. Rep. Nydia Velázquez in the 7th Congressional District, ...
Democratic Socialists of America members, New York City Mayor Zohran Mamdani’s political organization, have been cultivating connections with Chinese Communist Party officials and agreeing to take pro ...
New York City’s chapter of the Democratic Socialists of America (DSA) is organizing a large-scale effort to mobilize thousands of activists to respond to anticipated federal immigration enforcement ...
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Recursion Pharmaceuticals, Inc. before investing. In this article, we go over a ...
David Orkin, a staff attorney with immigration legal services non-profit Make the Road New York, officially launched his campaign to primary Assembly Member Jenifer Rajkumar in the 38th Assembly ...
Mayor Zohran Mamdani and United Auto Workers President Shawn Fain are flexing their political power and backing a democratic socialist in a high-profile race to replace Rep. Nydia Velázquez in a ...
European deep-tech investor DSA Holding AS has signed a letter of intent (LoI) to invest up to $2 billion in India’s emerging quantum and deep-tech ecosystem led by Innogress Ventures. This is one of ...
New York City Mayor-elect Zohran Mamdani’s victory over establishment Democrats has reverberated nationwide — energizing Democratic Socialists of America chapters — including in Las Vegas, where local ...
NYC Mayor-elect Zohran Mamdani said Saturday he’s endorsing a longtime “comrade” and fellow card-carrying member of the Democratic Socialists of America to replace him the state Legislature. DSA ...
Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...